Mérieux

bioMérieux is a global leader in the field of in vitro diagnostics, specializing in the diagnosis of infectious diseases and industrial microbiological control. The company develops and produces diagnostic systems—including reagents, instruments, and software—that are used to identify pathogens and determine antibiotic susceptibility. Its core business is centered on clinical applications such as microbiology, immunoassays, and molecular biology, with a strategic focus on combating antimicrobial resistance and improving sepsis management. bioMérieux's flagship platforms, including BIOFIRE for syndromic testing and VITEK for automated identification, are essential tools in hospitals and laboratories worldwide. Beyond clinical diagnostics, the company also provides solutions for the food, pharmaceutical, and cosmetic industries to ensure product safety and quality. Headquartered in France, bioMérieux operates in over 160 countries and is a key component of the Institut Mérieux group.